188 related articles for article (PubMed ID: 17321668)
1. Dutasteride prior to contrast-enhanced colour Doppler ultrasound prostate biopsy increases prostate cancer detection.
Mitterberger M; Pinggera G; Horninger W; Strasser H; Halpern E; Pallwein L; Gradl J; Bartsch G; Frauscher F
Eur Urol; 2008 Jan; 53(1):112-7. PubMed ID: 17321668
[TBL] [Abstract][Full Text] [Related]
2. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score.
Mitterberger M; Pinggera GM; Horninger W; Bartsch G; Strasser H; Schäfer G; Brunner A; Halpern EJ; Gradl J; Pallwein L; Frauscher F
J Urol; 2007 Aug; 178(2):464-8; discussion 468. PubMed ID: 17561137
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study.
Marberger M; Freedland SJ; Andriole GL; Emberton M; Pettaway C; Montorsi F; Teloken C; Rittmaster RS; Somerville MC; Castro R
BJU Int; 2012 Apr; 109(8):1162-9. PubMed ID: 21699645
[TBL] [Abstract][Full Text] [Related]
4. Effect of dutasteride therapy on Doppler US evaluation of prostate: preliminary results.
Ives EP; Gomella LG; Halpern EJ
Radiology; 2005 Oct; 237(1):197-201. PubMed ID: 16183933
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.
Pelzer A; Bektic J; Berger AP; Pallwein L; Halpern EJ; Horninger W; Bartsch G; Frauscher F
J Urol; 2005 Jun; 173(6):1926-9. PubMed ID: 15879783
[TBL] [Abstract][Full Text] [Related]
6. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced colour Doppler-targeted vs a 10-core systematic repeat biopsy strategy in patients with previous high-grade prostatic intraepithelial neoplasia.
Mitterberger M; Horninger W; Aigner F; Pinggera GM; Rehder P; Steiner E; Wiunig C; Reissigl A; Frauscher F
BJU Int; 2010 Jun; 105(12):1660-2. PubMed ID: 19863528
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride.
Andriole GL; Marberger M; Roehrborn CG
J Urol; 2006 May; 175(5):1657-62. PubMed ID: 16600723
[TBL] [Abstract][Full Text] [Related]
9. Contrast enhanced transrectal ultrasound for the detection of prostate cancer: a randomized, double-blind trial of dutasteride pretreatment.
Halpern EJ; Gomella LG; Forsberg F; McCue PA; Trabulsi EJ
J Urol; 2012 Nov; 188(5):1739-45. PubMed ID: 22998915
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection.
Mitterberger M; Horninger W; Pelzer A; Strasser H; Bartsch G; Moser P; Halpern EJ; Gradl J; Aigner F; Pallwein L; Frauscher F
Prostate; 2007 Oct; 67(14):1537-42. PubMed ID: 17705242
[TBL] [Abstract][Full Text] [Related]
11. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection.
Frauscher F; Klauser A; Volgger H; Halpern EJ; Pallwein L; Steiner H; Schuster A; Horninger W; Rogatsch H; Bartsch G
J Urol; 2002 Apr; 167(4):1648-52. PubMed ID: 11912381
[TBL] [Abstract][Full Text] [Related]
12. Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.
Roehrborn CG; Andriole GL; Wilson TH; Castro R; Rittmaster RS
Eur Urol; 2011 Feb; 59(2):244-9. PubMed ID: 21093145
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced colour Doppler-targeted prostate biopsy: correlation of a subjective blood-flow rating scale with the histopathological outcome of the biopsy.
Mitterberger M; Aigner F; Pinggera GM; Steiner E; Rehder P; Ulmer H; Halpern EJ; Horninger W; Frauscher F
BJU Int; 2010 Nov; 106(9):1315-8; discussion 1318. PubMed ID: 20346032
[TBL] [Abstract][Full Text] [Related]
14. Effect of short-term dutasteride therapy on prostate vascularity in patients with benign prostatic hyperplasia: a pilot study.
Kravchick S; Cytron S; Mamonov A; Peled R; Linov L
Urology; 2009 Jun; 73(6):1274-8. PubMed ID: 19375786
[TBL] [Abstract][Full Text] [Related]
15. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project.
Pelzer AE; Bektic J; Berger AP; Halpern EJ; Koppelstätter F; Klauser A; Rehder P; Horninger W; Bartsch G; Frauscher F
Eur Urol; 2005 Dec; 48(6):916-21; discussion 921. PubMed ID: 16126324
[TBL] [Abstract][Full Text] [Related]
16. Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasteride.
Muller RL; Gerber L; Moreira DM; Andriole G; Hamilton RJ; Fleshner N; Parsons JK; Freedland SJ
Eur Urol; 2013 Jun; 63(6):1115-21. PubMed ID: 23541458
[TBL] [Abstract][Full Text] [Related]
17. Consequences of switching 5alpha-reductase inhibitors on prostate specific antigen velocity.
Helfand BT; Blackwell RH; McVary KT
J Urol; 2010 Jul; 184(1):218-23. PubMed ID: 20483154
[TBL] [Abstract][Full Text] [Related]
18. Dutasteride, who is it more effective for? Second to fourth digit ratio and the relationship with prostate volume reduction by dutasteride treatment.
Kim TB; Oh JK; Kim KH; Jung H; Yoon SJ; Lee MS; Kim SW
BJU Int; 2012 Dec; 110(11 Pt C):E857-63. PubMed ID: 22755506
[TBL] [Abstract][Full Text] [Related]
19. Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasound and systematic random biopsies to detect prostate cancer.
Morelli G; Pagni R; Mariani C; Minervini R; Morelli A; Gori F; Ferdeghini EM; Paterni M; Mauro E; Guidi E; Armillotta N; Canale D; Vitti P; Caramella D; Minervini A
J Urol; 2011 Jun; 185(6):2126-31. PubMed ID: 21496853
[TBL] [Abstract][Full Text] [Related]
20. Detection of prostate cancer with a microbubble ultrasound contrast agent.
Frauscher F; Klauser A; Halpern EJ; Horninger W; Bartsch G
Lancet; 2001 Jun; 357(9271):1849-50. PubMed ID: 11410195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
